HYDRALAZINE-PYRIMIDINE INTERACTIONS MAY EXPLAIN HYDRALAZINE-INDUCED LUPUS-ERYTHEMATOSUS

被引：86
作者：
DUBROFF, LM
REID, RJ
机构：
来源：
SCIENCE | 1980年 / 208卷 / 4442期
关键词：
D O I：
10.1126/science.7367866
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：404 / 406
页数：3
相关论文
共 20 条
[11]   IMMUNE-RESPONSES TO HYDRALAZINE AND NUCLEAR ANTIGENS IN HYDRALAZINE-INDUCED LUPUS-ERYTHEMATOSUS [J].
HAHN, BH ;
IRVIN, WS ;
KANTOR, OS ;
BAGBY, MK ;
SHARP, GC ;
GARDNER, CA ;
OSTERLAND, CK ;
PERRY, HM .
ANNALS OF INTERNAL MEDICINE, 1972, 76 (03) :365-+
[12]   PERSISTENCE OF THE HYDRALAZINE SYNDROME - A FOLLOW-UP STUDY OF 11 CASES [J].
HILDRETH, EA ;
BIRO, CE ;
MCCREARY, TA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1960, 173 (06) :657-660
[13]   AGARITINE - ISOLATION, DEGRADATION, AND SYNTHESIS [J].
KELLY, RB ;
HINMAN, JW ;
DANIELS, EG .
JOURNAL OF ORGANIC CHEMISTRY, 1962, 27 (09) :3229-&
[14]   ACTIVATION OF SYSTEMIC LUPUS ERYTHEMATOSUS BY DRUGS [J].
LEE, SL ;
RIVERO, I ;
SIEGEL, M .
ARCHIVES OF INTERNAL MEDICINE, 1966, 117 (05) :620-&
[15]  
SHAPIRO H, 1968, METHODS ENZYMOL A, V12, P212
[16]  
STOLLAR BD, 1973, ANTIGENS, P1
[17]  
TALSETH T, 1977, CLIN PHARMACOL THER, V21, P715
[18]  
TAN E, 1978, IMMUNOLOGICAL DISEAS, V2, P1078
[19]  
TAN EM, 1974, FED PROC, V33, P1894
[20]  
TOTH B, 1975, CANCER RES, V35, P3693
12